Clinical trial
V-Chordal Adjustable System for Chordal Replacement in Mitral Valve Insufficiency Due to Leaflet Prolapse
NCT01415947 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- V-Chordal Adjustable System for Chordal Replacement in Mitral Valve Insufficiency Due to Leaflet Prolapse
- Lead sponsor
- Edwards Lifesciences
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- November 30, 2010
- Completion date
- March 31, 2013
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
mitral leaflet prolapse